|Bid||0.00 x 300000|
|Ask||0.00 x 300000|
|Day's Range||2,793.23 - 2,793.23|
|52 Week Range||2,587.99 - 3,261.20|
|PE Ratio (TTM)||132.28|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Jan.08 -- McKesson Corp. CEO John Hammergren speaks with Bloomberg’s Erik Schatzker at the JPMorgan Healthcare Conference about tech giants’ role in pharmaceuticals.
Jan.08 -- McKesson Corp. Chief Executive Officer John Hammergren speaks with Bloomberg’s Erik Schatzker at the JPMorgan Healthcare Conference and refutes criticism that his drug distribution company did not do enough to prevent the opioid epidemic.
Jan.08 -- McKesson Corp. chief executive officer John Hammergren speaks with Bloomberg’s Erik Schatzker at the JPMorgan Healthcare Conference and forcefully refutes criticism that his drug distribution company did not do enough to prevent the opioid epidemic. They also discuss technology giants' role in pharmaceuticals.
It could be weeks or a year before the deals that biotech executives and financiers started at last week's 36th J.P. Morgan Healthcare Conference come to fruition. McKesson Corp. (MCK), the San Francisco-based health care products distribution company, has been a target of those looking to find a source of the nation's epidemic of pain-killing opioid drugs.
In the Bloomberg video above , McKesson Corp. Chief Executive Officer John Hammergren refutes criticism that his drug distribution company did not do enough to prevent the opioid epidemic. Hammergren speaks with Bloomberg’s Erik Schatzker at the JPMorgan Healthcare Conference. The Washington Post and CBS' "60 Minutes" last month jointly reported on an investigation of McKesson led by the U.S. Drug Enforcement Administration's Denver team that looked into the pharmaceutical giant's distribution of powerful opioid prescription drugs in Colorado and elsewhere.
COLUMBUS, Ohio (AP) — A federal judge on Tuesday set a goal of doing something about the nation's opioid epidemic this year, while noting the drug crisis is "100 percent man-made."
In the past few weeks, McKesson has been unhappily tied to stories about opioids, including coverage on TheStreet. At the JPMorgan Healthcare Conference, the company took its case to investors.
McKesson Technologies LLC in Alpharetta has been awarded a $400 million federal contract to supply and maintain digital imaging network picture archiving and communication system products and maintenance. Change Healthcare and McKesson Technology Solutions, a division of McKesson Corp. (MCK), combined in March 2017 , and the McKesson Imaging business became a part of the new Change Healthcare, a Change Healthcare spokeswoman said. The contract has a five-year base with one five-year option period, according to the Department of Defense.
The crisis could seemingly turn a number of companies on their heads much in the way that big tobacco suits of the late 1990s forever changed the tobacco industry.
McKesson (MCK) has been actively pursuing deals, divestitures and acquisitions to drive growth. The latest buyout will boost Specialty Health business.
McKesson Corporation will release financial results for its third fiscal quarter ended December 31, 2017 on Thursday, February 1, 2018, prior to the opening of trading on the New York Stock Exchange.
McKesson Corporation , a global leader in healthcare supply chain management solutions, announced today that it has completed the previously announced acquisition of RxCrossroads.
Becton, Dickinson and Company (BDX), or BD, established itself as the leader in the medication management market with the acquisition of CareFusion in 2015.
The $1.3 billion acquisition of CoverMyMeds LLC – unmatched in tech history statewide – has paid dividends in continued job growth as well as attention. From the start, CEO Matt Scantland said the purchase by McKesson Corp. was “all about growth.” Indeed, CoverMyMeds added about 100 jobs to hit 600 by fall , and recently said it’s hiring “hundreds,” without specifying how many hundreds, at its Columbus headquarters, Cleveland office and telecommuters. “This deal secures the lasting success of CoverMyMeds,” CEO Matt Scantland said in an interview with Columbus Business First after the announcement.
McKesson Corporation today announced that John Hammergren, chairman and chief executive officer, will present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco at 8:30 a.m.
After years of investigation of McKesson Corp., led by a Denver-based Drug Enforcement Administration team, over the pharmaceutical giant's distribution of powerful opioid drugs in Colorado and elsewhere, DEA agents say they thought they had gathered enough evidence to warrant criminal charges and fines of more than $1 billion. The DEA probe examined whether San Francisco-based McKesson (MCK) failed to report suspicious orders of addictive opioid pain pills by pharmacies that in turn were supplying drug rings for illegal sale. “This is the best case we’ve ever had against a major distributor in the history of the [DEA]," David Schiller, who was assistant special agent in charge of the DEA’s Denver field division until his recent retirement, told the Washington Post.
Chairman, President & CEO of Mckesson Corp (NYSE:MCK) John H Hammergren sold 65,000 shares of MCK on 12/14/2017 at an average price of $160 a share.
Stocks that moved substantially or traded heavily Monday: Amplify Snack Brands Inc., up $5.01 to $12.01 The Pop Secret maker agreed to be bought by Hershey for $1.2 billion. Snyder's-Lance Inc., up $3.25 ...
McKesson Corp. said Monday Chief Financial Officer James Beer is leaving the company, and will be joining enterprise collaboration company Atlassian Corp. in February 2018. The stock slipped 0.6% in premarket ...
McKesson Corporation today announced James Beer, executive vice president and chief financial officer, will be leaving the company to pursue a new opportunity. Britt Vitalone, senior vice president and chief financial officer, U.S.
McKesson Corporation (NYSE:MCK) delivered an ROE of 39.56% over the past 12 months, which is an impressive feat relative to its industry average of 12.29% during the same period. Superficially,Read More...
McKesson Corp subsidiary McKesson Technologies LLC has been awarded a maximum $400 million contract for digital imaging network picture archiving communications system products and maintenance, the Pentagon ...